Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma
1 Ansichten
• 08/09/23
0
0
Einbetten
administrator
Abonnenten
Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare